バイオシミラー医薬品の世界市場2016

◆英語タイトル:Global Biosimilar Drug Industry 2016 Market Research Report
◆商品コード:QYR6062719
◆発行会社(調査会社):QYResearch
◆発行日:2016年5月
◆ページ数:155
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single UserUSD2,800 ⇒換算¥319,200見積依頼/購入/質問フォーム
Enterprise(全社内共有可)USD5,600 ⇒換算¥638,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規販売代理店です。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
本調査レポートでは、バイオシミラー医薬品の世界市場2016について調査・分析し、バイオシミラー医薬品の市場概要、市場動向、世界市場規模、市場規模予測、主要地域別市場規模(日本、アメリカ、ヨーロッパ、中国)、製造・コスト構造分析、技術データ及び製造工場分析、生産能力、生産規模、売上分析、価格、コスト、売上総利益分析、販売量、販売金額、販売価格分析、市場シェア分析、供給、輸入・輸出、消費分析、主要メーカー分析、販売企業(代理店)・流通企業分析、産業サプライチェーン分析、投資可能性分析などの情報をお届けいたします。

・バイオシミラー医薬品の世界市場概要
・バイオシミラー医薬品の世界市場規模、市場規模予測
・バイオシミラー医薬品の主要地域別市場規模(日本、アメリカ、ヨーロッパ、中国)
・バイオシミラー医薬品の世界市場動向
・バイオシミラー医薬品の製造・コスト構造分析
・バイオシミラー医薬品の技術データ及び製造工場分析
・バイオシミラー医薬品の生産能力、生産規模、売上分析
・バイオシミラー医薬品の価格、コスト、売上総利益分析
・バイオシミラー医薬品の販売量、販売金額、販売価格分析
・バイオシミラー医薬品の市場シェア分析
・バイオシミラー医薬品の供給、輸入、輸出、消費分析
・バイオシミラー医薬品の主要メーカー分析
・バイオシミラー医薬品の販売企業(代理店)・流通企業分析
・バイオシミラー医薬品の産業サプライチェーン分析
・バイオシミラー医薬品の投資可能性分析
...
【レポートの概要】

The Global Biosimilar Drug Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Biosimilar Drug industry.
Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Biosimilar Drug market analysis is provided for the international market including development history, competitive landscape analysis, and major regions’ development status.

Secondly, development policies and plans are discussed as well as manufacturing processes and cost structures. This report also states import/export, supply and consumption figures as well as cost, price, revenue and gross margin by regions (United States, EU, China and Japan), and other regions can be added.

Then, the report focuses on global major leading industry players with information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials, equipment and downstream consumers analysis is also carried out. What’s more, the Biosimilar Drug industry development trends and marketing channels are analyzed.

Finally, the feasibility of new investment projects is assessed, and overall research conclusions are offered.

In a word, the report provides major statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

【レポートの目次】

Table of Contents

1 Industry Overview of Biosimilar Drug
1.1 Definition and Specifications of Biosimilar Drug
1.1.1 Definition of Biosimilar Drug
1.1.2 Specifications of Biosimilar Drug
1.2 Classification of Biosimilar Drug
1.3 Applications of Biosimilar Drug
1.4 Industry Chain Structure of Biosimilar Drug
1.5 Industry Overview and Major Regions Status of Biosimilar Drug
1.5.1 Industry Overview of Biosimilar Drug
1.5.2 Global Major Regions Status of Biosimilar Drug
1.6 Industry Policy Analysis of Biosimilar Drug
1.7 Industry News Analysis of Biosimilar Drug

2 Manufacturing Cost Structure Analysis of Biosimilar Drug
2.1 Raw Material Suppliers and Price Analysis of Biosimilar Drug
2.2 Equipment Suppliers and Price Analysis of Biosimilar Drug
2.3 Labor Cost Analysis of Biosimilar Drug
2.4 Other Costs Analysis of Biosimilar Drug
2.5 Manufacturing Cost Structure Analysis of Biosimilar Drug
2.6 Manufacturing Process Analysis of Biosimilar Drug

3 Technical Data and Manufacturing Plants Analysis of Biosimilar Drug
3.1 Capacity and Commercial Production Date of Global Biosimilar Drug Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Biosimilar Drug Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global Biosimilar Drug Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Biosimilar Drug Major Manufacturers in 2015

4 Capacity, Production and Revenue Analysis of Biosimilar Drug by Regions, Types and Manufacturers
4.1 Global Capacity, Production and Revenue of Biosimilar Drug by Regions 2011-2016
4.2 Global and Major Regions Capacity, Production, Revenue and Growth Rate of Biosimilar Drug 2011-2016
4.3 Global Capacity, Production and Revenue of Biosimilar Drug by Types 2011-2016
4.4 Global Capacity, Production and Revenue of Biosimilar Drug by Manufacturers 2011-2016

5 Price, Cost, Gross and Gross Margin Analysis of Biosimilar Drug by Regions, Types and Manufacturers
5.1 Price, Cost, Gross and Gross Margin Analysis of Biosimilar Drug by Regions 2011-2016
5.2 Price, Cost, Gross and Gross Margin Analysis of Biosimilar Drug by Types 2011-2016
5.3 Price, Cost, Gross and Gross Margin Analysis of Biosimilar Drug by Manufacturers 2011-2016

6 Consumption Volume, Consumption Value and Sale Price Analysis of Biosimilar Drug by Regions, Types and Applications
6.1 Global Consumption Volume and Consumption Value of Biosimilar Drug by Regions 2011-2016
6.2 Global and Major Regions Consumption Volume, Consumption Value and Growth Rate of Biosimilar Drug 2011-2016
6.3 Global Consumption Volume and Consumption Value of Biosimilar Drug by Types 2011-2016
6.4 Global Consumption Volume and Consumption Value of Biosimilar Drug by Applications 2011-2016
6.5 Sale Price of Biosimilar Drug by Regions 2011-2016
6.6 Sale Price of Biosimilar Drug by Types 2011-2016
6.7 Sale Price of Biosimilar Drug by Applications 2011-2016
6.8 Market Share Analysis of Biosimilar Drug by Different Sale Price Levels

7 Supply, Import, Export and Consumption Analysis of Biosimilar Drug
7.1 Supply, Consumption and Gap of Biosimilar Drug 2011-2016
7.2 Global Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Biosimilar Drug 2011-2016
7.3 USA Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Biosimilar Drug 2011-2016
7.4 EU Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Biosimilar Drug 2011-2016
7.5 China Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Biosimilar Drug 2011-2016
7.6 Japan Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Biosimilar Drug 2011-2016

8 Major Manufacturers Analysis of Biosimilar Drug
8.1 Hospira
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Type I
8.1.2.2 Type II
8.1.2.3 Type III
8.1.3 Capacity, Production, Price, Cost, Gross and Revenue
8.1.4 Contact Information

8.2 Sandoz
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Type I
8.2.2.2 Type II
8.2.2.3 Type III
8.2.3 Capacity, Production, Price, Cost, Gross and Revenue
8.2.4 Contact Information

8.3 Teva Pharmaceutical Industries
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Type I
8.3.2.2 Type II
8.3.2.3 Type III
8.3.3 Capacity, Production, Price, Cost, Gross and Revenue
8.3.4 Contact Information

8.4 Pfizer
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Type I
8.4.2.2 Type II
8.4.2.3 Type III
8.4.3 Capacity, Production, Price, Cost, Gross and Revenue
8.4.4 Contact Information

8.5 Merck Sharp & Dohme
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Type I
8.5.2.2 Type II
8.5.2.3 Type III
8.5.3 Capacity, Production, Price, Cost, Gross and Revenue
8.5.4 Contact Information

8.6 Celltrion
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Type I
8.6.2.2 Type II
8.6.2.3 Type III
8.6.3 Capacity, Production, Price, Cost, Gross and Revenue
8.6.4 Contact Information

8.7 Amgen
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Type I
8.7.2.2 Type II
8.7.2.3 Type III
8.7.3 Capacity, Production, Price, Cost, Gross and Revenue
8.7.4 Contact Information

8.8 Biogen
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Type I
8.8.2.2 Type II
8.8.2.3 Type III
8.8.3 Capacity, Production, Price, Cost, Gross and Revenue
8.8.4 Contact Information

8.9 Mylan
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Type I
8.9.2.2 Type II
8.9.2.3 Type III
8.9.3 Capacity, Production, Price, Cost, Gross and Revenue
8.9.4 Contact Information

8.10 Biocon
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.2.1 Type I
8.10.2.2 Type II
8.10.2.3 Type III
8.10.3 Capacity, Production, Price, Cost, Gross and Revenue
8.10.4 Contact Information

8.11 Dr. Reddy’s Laboratories
8.11.1 Company Profile
8.11.2 Product Picture and Specifications
8.11.2.1 Type I
8.11.2.2 Type II
8.11.2.3 Type III
8.11.3 Capacity, Production, Price, Cost, Gross and Revenue
8.11.4 Contact Information

8.12 Boehringer Ingelheim GmbH
8.12.1 Company Profile
8.12.2 Product Picture and Specifications
8.12.2.1 Type I
8.12.2.2 Type II
8.12.2.3 Type III
8.12.3 Capacity, Production, Price, Cost, Gross and Revenue
8.12.4 Contact Information

8.13 Intas Pharmaceuticals
8.13.1 Company Profile
8.13.2 Product Picture and Specifications
8.13.2.1 Type I
8.13.2.2 Type II
8.13.2.3 Type III
8.13.3 Capacity, Production, Price, Cost, Gross and Revenue
8.13.4 Contact Information

8.14 LG Life Sciences
8.14.1 Company Profile
8.14.2 Product Picture and Specifications
8.14.2.1 Type I
8.14.2.2 Type II
8.14.2.3 Type III
8.14.3 Capacity, Production, Price, Cost, Gross and Revenue
8.14.4 Contact Information

8.15 Emcure Pharmaceuticals
8.15.1 Company Profile
8.15.2 Product Picture and Specifications
8.15.2.1 Type I
8.15.2.2 Type II
8.15.2.3 Type III
8.15.3 Capacity, Production, Price, Cost, Gross and Revenue
8.15.4 Contact Information

8.16 Probiomed
8.16.1 Company Profile
8.16.2 Product Picture and Specifications
8.16.2.1 Type I
8.16.2.2 Type II
8.16.2.3 Type III
8.16.3 Capacity, Production, Price, Cost, Gross and Revenue
8.16.4 Contact Information

8.17 Biosidus
8.17.1 Company Profile
8.17.2 Product Picture and Specifications
8.17.2.1 Type I
8.17.2.2 Type II
8.17.2.3 Type III
8.17.3 Capacity, Production, Price, Cost, Gross and Revenue
8.17.4 Contact Information

8.18 3SBio
8.18.1 Company Profile
8.18.2 Product Picture and Specifications
8.18.2.1 Type I
8.18.2.2 Type II
8.18.2.3 Type III
8.18.3 Capacity, Production, Price, Cost, Gross and Revenue
8.18.4 Contact Information

8.19 WOCKHARDT
8.19.1 Company Profile
8.19.2 Product Picture and Specifications
8.19.2.1 Type I
8.19.2.2 Type II
8.19.2.3 Type III
8.19.3 Capacity, Production, Price, Cost, Gross and Revenue
8.19.4 Contact Information

8.20 Sun Pharmaceutical Industries
8.20.1 Company Profile
8.20.2 Product Picture and Specifications
8.20.2.1 Type I
8.20.2.2 Type II
8.20.2.3 Type III
8.20.3 Capacity, Production, Price, Cost, Gross and Revenue
8.20.4 Contact Information

8.21 Shanghai Fosun Pharmaceutical
8.21.1 Company Profile
8.21.2 Product Picture and Specifications
8.21.2.1 Type I
8.21.2.2 Type II
8.21.2.3 Type III
8.21.3 Capacity, Production, Price, Cost, Gross and Revenue
8.21.4 Contact Information

8.22 Qilu Pharmaceutical
8.22.1 Company Profile
8.22.2 Product Picture and Specifications
8.22.2.1 Type I
8.22.2.2 Type II
8.22.2.3 Type III
8.22.3 Capacity, Production, Price, Cost, Gross and Revenue
8.22.4 Contact Information

8.23 Allergan
8.23.1 Company Profile
8.23.2 Product Picture and Specifications
8.23.2.1 Type I
8.23.2.2 Type II
8.23.2.3 Type III
8.23.3 Capacity, Production, Price, Cost, Gross and Revenue
8.23.4 Contact Information

8.24 Dongbao
8.24.1 Company Profile
8.24.2 Product Picture and Specifications
8.24.2.1 Type I
8.24.2.2 Type II
8.24.2.3 Type III
8.24.3 Capacity, Production, Price, Cost, Gross and Revenue
8.24.4 Contact Information

8.25 Samsung Biologics
8.25.1 Company Profile
8.25.2 Product Picture and Specifications
8.25.2.1 Type I
8.25.2.2 Type II
8.25.2.3 Type III
8.25.3 Capacity, Production, Price, Cost, Gross and Revenue
8.25.4 Contact Information

8.26 Zydus Cadila.
8.26.1 Company Profile
8.26.2 Product Picture and Specifications
8.26.2.1 Type I
8.26.2.2 Type II
8.26.2.3 Type III
8.26.3 Capacity, Production, Price, Cost, Gross and Revenue
8.26.4 Contact Information

8.27 Dong-A Pharmaceutical
8.27.1 Company Profile
8.27.2 Product Picture and Specifications
8.27.2.1 Type I
8.27.2.2 Type II
8.27.2.3 Type III
8.27.3 Capacity, Production, Price, Cost, Gross and Revenue
8.27.4 Contact Information

9 Marketing Trader or Distributor Analysis of Biosimilar Drug
9.1 Marketing Channels Status of Biosimilar Drug
9.2 Traders or Distributors with Contact Information of Biosimilar Drug by Regions
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Biosimilar Drug
9.4 Regional Import, Export and Trade Analysis of Biosimilar Drug

10 Industry Chain Analysis of Biosimilar Drug
10.1 Upstream Major Raw Materials Suppliers Analysis of Biosimilar Drug
10.1.1 Major Raw Materials Suppliers with Contact Information Analysis of Biosimilar Drug
10.1.2 Major Raw Materials Suppliers with Supply Volume Analysis of Biosimilar Drug by Regions
10.2 Upstream Major Equipment Suppliers Analysis of Biosimilar Drug
10.2.1 Major Equipment Suppliers with Contact Information Analysis of Biosimilar Drug
10.2.2 Major Equipment Suppliers with Product Pictures Analysis of Biosimilar Drug by Regions
10.3 Downstream Major Consumers Analysis of Biosimilar Drug
10.3.1 Major Consumers with Contact Information Analysis of Biosimilar Drug
10.3.2 Major Consumers with Consumption Volume Analysis of Biosimilar Drug by Regions
10.4 Supply Chain Relationship Analysis of Biosimilar Drug

11 Development Trend of Analysis of Biosimilar Drug
11.1 Capacity, Production and Revenue Forecast of Biosimilar Drug by Regions and Types
11.1.1 Global Capacity, Production and Revenue of Biosimilar Drug by Regions 2016-2021
11.1.2 Global and Major Regions Capacity, Production, Revenue and Growth Rate of Biosimilar Drug 2016-2021
11.1.3 Global Capacity, Production and Revenue of Biosimilar Drug by Types 2016-2021
11.2 Consumption Volume and Consumption Value Forecast of Biosimilar Drug by Regions, Types and Applications
11.2.1 Global Consumption Volume and Consumption Value of Biosimilar Drug by Regions 2016-2021
11.2.2 Global and Major Regions Consumption Volume, Consumption Value and Growth Rate of Biosimilar Drug 2016-2021
11.2.3 Global Consumption Volume and Consumption Value of Biosimilar Drug by Types 2016-2021
11.2.4 Global Consumption Volume and Consumption Value of Biosimilar Drug by Applications 2016-2021
11.3 Supply, Import, Export and Consumption Forecast of Biosimilar Drug
11.3.1 Supply, Consumption and Gap of Biosimilar Drug 2016-2021
11.3.2 Global Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Biosimilar Drug 2016-2021
11.3.3 USA Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Biosimilar Drug 2016-2021
11.3.4 EU Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Biosimilar Drug 2016-2021
11.3.5 China Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Biosimilar Drug 2016-2021
11.3.6 Japan Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Biosimilar Drug 2016-2021

12 New Project Investment Feasibility Analysis of Biosimilar Drug
12.1 New Project SWOT Analysis of Biosimilar Drug
12.2 New Project Investment Feasibility Analysis of Biosimilar Drug

13 Conclusion of the Global Biosimilar Drug Industry 2016 Market Research Report

List of Tables and Figures
Figure Picture of Biosimilar Drug
Table Product Specifications of Biosimilar Drug
Table Classification of Biosimilar Drug
Figure Global Production Market Share of Biosimilar Drug by Types in 2015
Table Applications of Biosimilar Drug
Figure Global Consumption Volume Market Share of Biosimilar Drug by Applications in 2015
Figure Industry Chain Structure of Biosimilar Drug
Table Global Biosimilar Drug Major Manufacturers
Table Global Major Regions Biosimilar Drug Development Status
Table Industry Policy of Biosimilar Drug
Table Industry News List of Biosimilar Drug
Table Raw Material Suppliers and Price Analysis
Table Equipment Suppliers and Price Analysis
Table Manufacturing Cost Structure Analysis of Biosimilar Drug in 2015
Figure Manufacturing Process Analysis of Biosimilar Drug
Table Capacity (K Dose) and Commercial Production Date of Global Biosimilar Drug Major Manufacturers in 2015
Table Manufacturing Plants Distribution of Global Biosimilar Drug Major Manufacturers in 2015
Table R&D Status and Technology Source of Global Biosimilar Drug Major Manufacturers in 2015
Table Raw Materials Sources Analysis of Global Biosimilar Drug Major Manufacturers in 2015
Table Global Capacity (K Dose) of Biosimilar Drug by Regions 2011-2016
Figure Global Capacity Market Share of Biosimilar Drug by Regions in 2011
Figure Global Capacity Market Share of Biosimilar Drug by Regions in 2015
Table Global Production (K Dose) of Biosimilar Drug by Regions 2011-2016
Figure Global Production Market Share of Biosimilar Drug by Regions in 2011
Figure Global Production Market Share of Biosimilar Drug by Regions in 2015
Table Global Revenue (M USD) of Biosimilar Drug by Regions 2011-2016
Figure Global Revenue Market Share of Biosimilar Drug by Regions in 2011
Figure Global Revenue Market Share of Biosimilar Drug by Regions in 2015
Figure Global Capacity (K Dose), Production (K Dose) and Growth Rate of Biosimilar Drug 2011-2016
Figure Global Capacity Utilization Rate of Biosimilar Drug 2011-2016
Figure Global Revenue (M USD) and Growth Rate of Biosimilar Drug 2011-2016
Figure USA Capacity (K Dose), Production (K Dose) and Growth Rate of Biosimilar Drug 2011-2016
Figure USA Capacity Utilization Rate of Biosimilar Drug 2011-2016
Figure USA Revenue (M USD) and Growth Rate of Biosimilar Drug 2011-2016
Figure EU Capacity (K Dose), Production (K Dose) and Growth Rate of Biosimilar Drug 2011-2016
Figure EU Capacity Utilization Rate of Biosimilar Drug 2011-2016
Figure EU Revenue (M USD) and Growth Rate of Biosimilar Drug 2011-2016
Figure China Capacity (K Dose), Production (K Dose) and Growth Rate of Biosimilar Drug 2011-2016
Figure China Capacity Utilization Rate of Biosimilar Drug 2011-2016
Figure China Revenue (M USD) and Growth Rate of Biosimilar Drug 2011-2016
Figure Japan Capacity (K Dose), Production (K Dose) and Growth Rate of Biosimilar Drug 2011-2016
Figure Japan Capacity Utilization Rate of Biosimilar Drug 2011-2016
Figure Japan Revenue (M USD) and Growth Rate of Biosimilar Drug 2011-2016
Table Global Capacity (K Dose) of Biosimilar Drug by Types 2011-2016
Figure Global Capacity Market Share of Biosimilar Drug by Types in 2011
Figure Global Capacity Market Share of Biosimilar Drug by Types in 2015
Table Global Production (K Dose) of Biosimilar Drug by Types 2011-2016
Figure Global Production Market Share of Biosimilar Drug by Types in 2011
Figure Global Production Market Share of Biosimilar Drug by Types in 2015
Table Global Revenue (M USD) of Biosimilar Drug by Types 2011-2016
Figure Global Revenue Market Share of Biosimilar Drug by Types in 2011
Figure Global Revenue Market Share of Biosimilar Drug by Types in 2015
Table Global and Major Manufacturers Capacity (K Dose) of Biosimilar Drug 2011-2016
Table Global Capacity Market Share of Biosimilar Drug Major Manufacturers 2011-2016
Figure Global Capacity Market Share of Biosimilar Drug Major Manufacturers in 2011
Figure Global Capacity Market Share of Biosimilar Drug Major Manufacturers in 2015
Table Global and Major Manufacturers Production (K Dose) of Biosimilar Drug 2011-2016
Table Global Production Market Share of Biosimilar Drug Major Manufacturers 2011-2016
Figure Global Production Market Share of Biosimilar Drug Major Manufacturers in 2011
Figure Global Production Market Share of Biosimilar Drug Major Manufacturers in 2015
Table Global and Major Manufacturers Revenue (M USD) of Biosimilar Drug 2011-2016
Table Global Revenue Market Share of Biosimilar Drug Major Manufacturers 2011-2016
Figure Global Revenue Market Share of Biosimilar Drug Major Manufacturers in 2011
Figure Global Revenue Market Share of Biosimilar Drug Major Manufacturers in 2015
Table Price (USD/Dose) of Biosimilar Drug by Regions 2011-2016
Figure Price (USD/Dose) of Biosimilar Drug by Regions in 2015
Table Cost (USD/Dose) of Biosimilar Drug by Regions 2011-2016
Figure Cost (USD/Dose) of Biosimilar Drug by Regions in 2015
Table Gross (USD/Dose) of Biosimilar Drug by Regions 2011-2016
Figure Gross (USD/Dose) of Biosimilar Drug by Regions in 2015
Table Gross Margin of Biosimilar Drug by Regions 2011-2016
Figure Gross Margin of Biosimilar Drug by Regions in 2015
Table Price (USD/Dose) of Biosimilar Drug by Types 2011-2016
Figure Price (USD/Dose) of Biosimilar Drug by Types in 2015
Table Cost (USD/Dose) of Biosimilar Drug by Types 2011-2016
Figure Cost (USD/Dose) of Biosimilar Drug by Types in 2015
Table Gross (USD/Dose) of Biosimilar Drug by Types 2011-2016
Figure Gross (USD/Dose) of Biosimilar Drug by Types in 2015
Table Gross Margin of Biosimilar Drug by Types 2011-2016
Figure Gross Margin of Biosimilar Drug by Types in 2015
Table Price (USD/Dose) of Biosimilar Drug by Manufacturers 2011-2016
Figure Price (USD/Dose) of Biosimilar Drug by Manufacturers in 2015
Table Cost (USD/Dose) of Biosimilar Drug by Manufacturers 2011-2016
Figure Cost (USD/Dose) of Biosimilar Drug by Manufacturers in 2015
Table Gross (USD/Dose) of Biosimilar Drug by Manufacturers 2011-2016
Figure Gross (USD/Dose) of Biosimilar Drug by Manufacturers in 2015
Table Gross Margin of Biosimilar Drug by Manufacturers 2011-2016
Figure Gross Margin of Biosimilar Drug by Manufacturers in 2015
Table Global Consumption Volume (K Dose) of Biosimilar Drug by Regions 2011-2016
Figure Global Consumption Volume Market Share of Biosimilar Drug by Regions in 2011
Figure Global Consumption Volume Market Share of Biosimilar Drug by Regions in 2015
Table Global Consumption Value (M USD) of Biosimilar Drug by Regions 2011-2016
Figure Global Consumption Value Market Share of Biosimilar Drug by Regions in 2011
Figure Global Consumption Value Market Share of Biosimilar Drug by Regions in 2015
Figure Global Consumption Volume (K Dose) and Growth Rate of Biosimilar Drug 2011-2016
Figure Global Consumption Value (M USD) and Growth Rate of Biosimilar Drug 2011-2016
Figure USA Consumption Volume (K Dose) and Growth Rate of Biosimilar Drug 2011-2016
Figure USA Consumption Value (M USD) and Growth Rate of Biosimilar Drug 2011-2016
Figure EU Consumption Volume (K Dose) and Growth Rate of Biosimilar Drug 2011-2016
Figure EU Consumption Value (M USD) and Growth Rate of Biosimilar Drug 2011-2016
Figure China Consumption Volume (K Dose) and Growth Rate of Biosimilar Drug 2011-2016
Figure China Consumption Value (M USD) and Growth Rate of Biosimilar Drug 2011-2016
Figure Japan Consumption Volume (K Dose) and Growth Rate of Biosimilar Drug 2011-2016
Figure Japan Consumption Value (M USD) and Growth Rate of Biosimilar Drug 2011-2016
Table Global Consumption Volume (K Dose) of Biosimilar Drug by Types 2011-2016
Figure Global Consumption Volume Market Share of Biosimilar Drug by Types in 2011
Figure Global Consumption Volume Market Share of Biosimilar Drug by Types in 2015
Table Global Consumption Value (M USD) of Biosimilar Drug by Types 2011-2016
Figure Global Consumption Value Market Share of Biosimilar Drug by Types in 2011
Figure Global Consumption Value Market Share of Biosimilar Drug by Types in 2015
Table Global Consumption Volume (K Dose) of Biosimilar Drug by Applications 2011-2016
Figure Global Consumption Volume Market Share of Biosimilar Drug by Applications in 2011
Figure Global Consumption Volume Market Share of Biosimilar Drug by Applications in 2015
Table Global Consumption Value (M USD) of Biosimilar Drug by Applications 2011-2016
Figure Global Consumption Value Market Share of Biosimilar Drug by Applications in 2011
Figure Global Consumption Value Market Share of Biosimilar Drug by Applications in 2015
Table Sale Price (USD/Dose) of Biosimilar Drug by Regions 2011-2016
Figure Sale Price (USD/Dose) of Biosimilar Drug by Regions in 2015
Table Sale Price (USD/Dose) of Biosimilar Drug by Types 2011-2016
Figure Sale Price (USD/Dose) of Biosimilar Drug by Types in 2015
Table Sale Price (USD/Dose) of Biosimilar Drug by Applications 2011-2016
Figure Sale Price (USD/Dose) of Biosimilar Drug by Applications in 2015
Table Market Share of Biosimilar Drug by Different Sale Price Levels
Table Global Supply, Consumption and Gap of Biosimilar Drug 2011-2016 (K Dose)
Table USA Supply, Consumption and Gap of Biosimilar Drug 2011-2016 (K Dose)
Table EU Supply, Consumption and Gap of Biosimilar Drug 2011-2016 (K Dose)
Table China Supply, Consumption and Gap of Biosimilar Drug 2011-2016 (K Dose)
Table Japan Supply, Consumption and Gap of Biosimilar Drug 2011-2016 (K Dose)
Table Global Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Biosimilar Drug 2011-2016
Table USA Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Biosimilar Drug 2011-2016
Table USA Supply, Import, Export and Consumption of Biosimilar Drug 2011-2016 (K Dose)
Table EU Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Biosimilar Drug 2011-2016
Table EU Supply, Import, Export and Consumption of Biosimilar Drug 2011-2016 (K Dose)
Table China Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Biosimilar Drug 2011-2016
Table China Supply, Import, Export and Consumption of Biosimilar Drug 2011-2016 (K Dose)
Table Japan Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Biosimilar Drug 2011-2016
Table Japan Supply, Import, Export and Consumption of Biosimilar Drug 2011-2016 (K Dose)
Table Hospira Information List
Figure Biosimilar Drug Picture and Specifications of Hospira
Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Hospira 2011-2016
Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Hospira 2011-2016
Figure Biosimilar Drug Production (K Dose) and Global Market Share of Hospira 2011-2016
Table Sandoz Information List
Figure Biosimilar Drug Picture and Specifications of Sandoz
Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Sandoz 2011-2016
Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Sandoz 2011-2016
Figure Biosimilar Drug Production (K Dose) and Global Market Share of Sandoz 2011-2016
Table Teva Pharmaceutical Industries Information List
Figure Biosimilar Drug Picture and Specifications of Teva Pharmaceutical Industries
Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Teva Pharmaceutical Industries 2011-2016
Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Teva Pharmaceutical Industries 2011-2016
Figure Biosimilar Drug Production (K Dose) and Global Market Share of Teva Pharmaceutical Industries 2011-2016
Table Pfizer Information List
Figure Biosimilar Drug Picture and Specifications of Pfizer
Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Pfizer 2011-2016
Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Pfizer 2011-2016
Figure Biosimilar Drug Production (K Dose) and Global Market Share of Pfizer 2011-2016
Table Merck Sharp & Dohme Information List
Figure Biosimilar Drug Picture and Specifications of Merck Sharp & Dohme
Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Merck Sharp & Dohme 2011-2016
Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Merck Sharp & Dohme 2011-2016
Figure Biosimilar Drug Production (K Dose) and Global Market Share of Merck Sharp & Dohme 2011-2016
Table Celltrion Information List
Figure Biosimilar Drug Picture and Specifications of Celltrion
Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Celltrion 2011-2016
Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Celltrion 2011-2016
Figure Biosimilar Drug Production (K Dose) and Global Market Share of Celltrion 2011-2016
Table Amgen Information List
Figure Biosimilar Drug Picture and Specifications of Amgen
Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Amgen 2011-2016
Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Amgen 2011-2016
Figure Biosimilar Drug Production (K Dose) and Global Market Share of Amgen 2011-2016
Table Biogen Information List
Figure Biosimilar Drug Picture and Specifications of Biogen
Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Biogen 2011-2016
Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Biogen 2011-2016
Figure Biosimilar Drug Production (K Dose) and Global Market Share of Biogen 2011-2016
Table Mylan Information List
Figure Biosimilar Drug Picture and Specifications of Mylan
Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Mylan 2011-2016
Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Mylan 2011-2016
Figure Biosimilar Drug Production (K Dose) and Global Market Share of Mylan 2011-2016
Table Biocon Information List
Figure Biosimilar Drug Picture and Specifications of Biocon
Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Biocon 2011-2016
Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Biocon 2011-2016
Figure Biosimilar Drug Production (K Dose) and Global Market Share of Biocon 2011-2016
Table Dr. Reddy’s Laboratories Information List
Figure Biosimilar Drug Picture and Specifications of Dr. Reddy’s Laboratories
Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Dr. Reddy’s Laboratories 2011-2016
Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Dr. Reddy’s Laboratories 2011-2016
Figure Biosimilar Drug Production (K Dose) and Global Market Share of Dr. Reddy’s Laboratories 2011-2016
Table Boehringer Ingelheim GmbH Information List
Figure Biosimilar Drug Picture and Specifications of Boehringer Ingelheim GmbH
Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Boehringer Ingelheim GmbH 2011-2016
Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Boehringer Ingelheim GmbH 2011-2016
Figure Biosimilar Drug Production (K Dose) and Global Market Share of Boehringer Ingelheim GmbH 2011-2016
Table Intas Pharmaceuticals Information List
Figure Biosimilar Drug Picture and Specifications of Intas Pharmaceuticals
Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Intas Pharmaceuticals 2011-2016
Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Intas Pharmaceuticals 2011-2016
Figure Biosimilar Drug Production (K Dose) and Global Market Share of Intas Pharmaceuticals 2011-2016
Table LG Life Sciences Information List
Figure Biosimilar Drug Picture and Specifications of LG Life Sciences
Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of LG Life Sciences 2011-2016
Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of LG Life Sciences 2011-2016
Figure Biosimilar Drug Production (K Dose) and Global Market Share of LG Life Sciences 2011-2016
Table Emcure Pharmaceuticals Information List
Figure Biosimilar Drug Picture and Specifications of Emcure Pharmaceuticals
Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Emcure Pharmaceuticals 2011-2016
Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Emcure Pharmaceuticals 2011-2016
Figure Biosimilar Drug Production (K Dose) and Global Market Share of Emcure Pharmaceuticals 2011-2016
Table Probiomed Information List
Figure Biosimilar Drug Picture and Specifications of Probiomed
Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Probiomed 2011-2016
Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Probiomed 2011-2016
Figure Biosimilar Drug Production (K Dose) and Global Market Share of Probiomed 2011-2016
Table Biosidus Information List
Figure Biosimilar Drug Picture and Specifications of Biosidus
Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Biosidus 2011-2016
Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Biosidus 2011-2016
Figure Biosimilar Drug Production (K Dose) and Global Market Share of Biosidus 2011-2016
Table 3SBio Information List
Figure Biosimilar Drug Picture and Specifications of 3SBio
Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of 3SBio 2011-2016
Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of 3SBio 2011-2016
Figure Biosimilar Drug Production (K Dose) and Global Market Share of 3SBio 2011-2016
Table WOCKHARDT Information List
Figure Biosimilar Drug Picture and Specifications of WOCKHARDT
Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of WOCKHARDT 2011-2016
Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of WOCKHARDT 2011-2016
Figure Biosimilar Drug Production (K Dose) and Global Market Share of WOCKHARDT 2011-2016
Table Sun Pharmaceutical Industries Information List
Figure Biosimilar Drug Picture and Specifications of Sun Pharmaceutical Industries
Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Sun Pharmaceutical Industries 2011-2016
Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Sun Pharmaceutical Industries 2011-2016
Figure Biosimilar Drug Production (K Dose) and Global Market Share of Sun Pharmaceutical Industries 2011-2016
Table Shanghai Fosun Pharmaceutical Information List
Figure Biosimilar Drug Picture and Specifications of Shanghai Fosun Pharmaceutical
Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Shanghai Fosun Pharmaceutical 2011-2016
Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Shanghai Fosun Pharmaceutical 2011-2016
Figure Biosimilar Drug Production (K Dose) and Global Market Share of Shanghai Fosun Pharmaceutical 2011-2016
Table Qilu Pharmaceutical Information List
Figure Biosimilar Drug Picture and Specifications of Qilu Pharmaceutical
Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Qilu Pharmaceutical 2011-2016
Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Qilu Pharmaceutical 2011-2016
Figure Biosimilar Drug Production (K Dose) and Global Market Share of Qilu Pharmaceutical 2011-2016
Table Allergan Information List
Figure Biosimilar Drug Picture and Specifications of Allergan
Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Allergan 2011-2016
Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Allergan 2011-2016
Figure Biosimilar Drug Production (K Dose) and Global Market Share of Allergan 2011-2016
Table Dongbao Information List
Figure Biosimilar Drug Picture and Specifications of Dongbao
Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Dongbao 2011-2016
Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Dongbao 2011-2016
Figure Biosimilar Drug Production (K Dose) and Global Market Share of Dongbao 2011-2016
Table Samsung Biologics Information List
Figure Biosimilar Drug Picture and Specifications of Samsung Biologics
Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Samsung Biologics 2011-2016
Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Samsung Biologics 2011-2016
Figure Biosimilar Drug Production (K Dose) and Global Market Share of Samsung Biologics 2011-2016
Table Zydus Cadila. Information List
Figure Biosimilar Drug Picture and Specifications of Zydus Cadila.
Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Zydus Cadila. 2011-2016
Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Zydus Cadila. 2011-2016
Figure Biosimilar Drug Production (K Dose) and Global Market Share of Zydus Cadila. 2011-2016
Table Dong-A Pharmaceutical Information List
Figure Biosimilar Drug Picture and Specifications of Dong-A Pharmaceutical
Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Dong-A Pharmaceutical 2011-2016
Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Dong-A Pharmaceutical 2011-2016
Figure Biosimilar Drug Production (K Dose) and Global Market Share of Dong-A Pharmaceutical 2011-2016
Figure Marketing Channels of Biosimilar Drug
Table Traders or Distributors with Contact Information of Biosimilar Drug by Regions
Table Ex-work Price, Channel Price and End Buyer Price of Biosimilar Drug (USD/Dose)
Table Regional Import, Export, and Trade of Biosimilar Drug (K Dose)
Table Flow of International Trade in 2015
Table Major Raw Materials Suppliers with Contact Information of Biosimilar Drug
Table Major Raw Materials Suppliers with Supply Volume of Biosimilar Drug by Regions
Table Major Equipment Suppliers with Contact Information of Biosimilar Drug
Table Major Equipment Suppliers with Product Pictures of Biosimilar Drug by Regions
Table Major Consumers with Contact Information of Biosimilar Drug
Table Major Consumers with Consumption Volume of Biosimilar Drug by Regions
Figure Supply Chain Relationship Analysis of Biosimilar Drug
Table Global Capacity (K Dose) of Biosimilar Drug by Regions 2016-2021
Figure Global Capacity Market Share of Biosimilar Drug by Regions in 2016
Figure Global Capacity Market Share of Biosimilar Drug by Regions in 2021
Table Global Production (K Dose) of Biosimilar Drug by Regions 2016-2021
Figure Global Production Market Share of Biosimilar Drug by Regions in 2016
Figure Global Production Market Share of Biosimilar Drug by Regions in 2021
Table Global Revenue (M USD) of Biosimilar Drug by Regions 2016-2021
Figure Global Revenue Market Share of Biosimilar Drug by Regions in 2016
Figure Global Revenue Market Share of Biosimilar Drug by Regions in 2021
Figure Global Capacity (K Dose), Production (K Dose) and Growth Rate of Biosimilar Drug 2016-2021
Figure Global Capacity Utilization Rate of Biosimilar Drug 2016-2021
Figure Global Revenue (M USD) and Growth Rate of Biosimilar Drug 2016-2021
Figure USA Capacity (K Dose), Production (K Dose) and Growth Rate of Biosimilar Drug 2016-2021
Figure USA Capacity Utilization Rate of Biosimilar Drug 2016-2021
Figure USA Revenue (M USD) and Growth Rate of Biosimilar Drug 2016-2021
Figure EU Capacity (K Dose), Production (K Dose) and Growth Rate of Biosimilar Drug 2016-2021
Figure EU Capacity Utilization Rate of Biosimilar Drug 2016-2021
Figure EU Revenue (M USD) and Growth Rate of Biosimilar Drug 2016-2021
Figure China Capacity (K Dose), Production (K Dose) and Growth Rate of Biosimilar Drug 2016-2021
Figure China Capacity Utilization Rate of Biosimilar Drug 2016-2021
Figure China Revenue (M USD) and Growth Rate of Biosimilar Drug 2016-2021
Figure Japan Capacity (K Dose), Production (K Dose) and Growth Rate of Biosimilar Drug 2016-2021
Figure Japan Capacity Utilization Rate of Biosimilar Drug 2016-2021
Figure Japan Revenue (M USD) and Growth Rate of Biosimilar Drug 2016-2021
Table Global Capacity (K Dose) of Biosimilar Drug by Types 2016-2021
Figure Global Capacity Market Share of Biosimilar Drug by Types in 2016
Figure Global Capacity Market Share of Biosimilar Drug by Types in 2021
Table Global Production (K Dose) of Biosimilar Drug by Types 2016-2021
Figure Global Production Market Share of Biosimilar Drug by Types in 2016
Figure Global Production Market Share of Biosimilar Drug by Types in 2021
Table Global Revenue (M USD) of Biosimilar Drug by Types 2016-2021
Figure Global Revenue Market Share of Biosimilar Drug by Types in 2016
Figure Global Revenue Market Share of Biosimilar Drug by Types in 2021
Table Global Consumption Volume (K Dose) of Biosimilar Drug by Regions 2016-2021
Figure Global Consumption Volume Market Share of Biosimilar Drug by Regions in 2016
Figure Global Consumption Volume Market Share of Biosimilar Drug by Regions in 2021
Table Global Consumption Value (M USD) of Biosimilar Drug by Regions 2016-2021
Figure Global Consumption Value Market Share of Biosimilar Drug by Regions in 2016
Figure Global Consumption Value Market Share of Biosimilar Drug by Regions in 2021
Figure Global Consumption Volume (K Dose) and Growth Rate of Biosimilar Drug 2016-2021
Figure Global Consumption Value (M USD) and Growth Rate of Biosimilar Drug 2016-2021
Figure USA Consumption Volume (K Dose) and Growth Rate of Biosimilar Drug 2016-2021
Figure USA Consumption Value (M USD) and Growth Rate of Biosimilar Drug 2016-2021
Figure EU Consumption Volume (K Dose) and Growth Rate of Biosimilar Drug 2016-2021
Figure EU Consumption Value (M USD) and Growth Rate of Biosimilar Drug 2016-2021
Figure China Consumption Volume (K Dose) and Growth Rate of Biosimilar Drug 2016-2021
Figure China Consumption Value (M USD) and Growth Rate of Biosimilar Drug 2016-2021
Figure Japan Consumption Volume (K Dose) and Growth Rate of Biosimilar Drug 2016-2021
Figure Japan Consumption Value (M USD) and Growth Rate of Biosimilar Drug 2016-2021
Table Global Consumption Volume (K Dose) of Biosimilar Drug by Types 2016-2021
Figure Global Consumption Volume Market Share of Biosimilar Drug by Types in 2016
Figure Global Consumption Volume Market Share of Biosimilar Drug by Types in 2021
Table Global Consumption Value (M USD) of Biosimilar Drug by Types 2016-2021
Figure Global Consumption Value Market Share of Biosimilar Drug by Types in 2016
Figure Global Consumption Value Market Share of Biosimilar Drug by Types in 2021
Table Global Consumption Volume (K Dose) of Biosimilar Drug by Applications 2016-2021
Figure Global Consumption Volume Market Share of Biosimilar Drug by Applications in 2016
Figure Global Consumption Volume Market Share of Biosimilar Drug by Applications in 2021
Table Global Consumption Value (M USD) of Biosimilar Drug by Applications 2016-2021
Figure Global Consumption Value Market Share of Biosimilar Drug by Applications in 2016
Figure Global Consumption Value Market Share of Biosimilar Drug by Applications in 2021
Table Global Supply, Consumption and Gap of Biosimilar Drug 2016-2021 (K Dose)
Table USA Supply, Consumption and Gap of Biosimilar Drug 2016-2021 (K Dose)
Table EU Supply, Consumption and Gap of Biosimilar Drug 2016-2021 (K Dose)
Table China Supply, Consumption and Gap of Biosimilar Drug 2016-2021 (K Dose)
Table Japan Supply, Consumption and Gap of Biosimilar Drug 2016-2021 (K Dose)
Table Global Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Biosimilar Drug 2016-2021
Table USA Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Biosimilar Drug 2016-2021
Table USA Supply, Import, Export and Consumption of Biosimilar Drug 2016-2021 (K Dose)
Table EU Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Biosimilar Drug 2016-2021
Table EU Supply, Import, Export and Consumption of Biosimilar Drug 2016-2021 (K Dose)
Table China Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Biosimilar Drug 2016-2021
Table China Supply, Import, Export and Consumption of Biosimilar Drug 2016-2021 (K Dose)
Table Japan Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Biosimilar Drug 2016-2021
Table Japan Supply, Import, Export and Consumption of Biosimilar Drug 2016-2021 (K Dose)
Table New Project SWOT Analysis of Biosimilar Drug
Table New Project Investment Feasibility Analysis of Biosimilar Drug
Table Part of Interviewees Record List


★調査レポート[バイオシミラー医薬品の世界市場2016]販売に関する免責事項
★調査レポート[バイオシミラー医薬品の世界市場2016]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆